Clinical Trial Update: Safety, Tolerability and Efficacy Study of the New Medication ASK8007 to Treat Patients With Rheumatoid Arthritis [Phase 1, Phase 2]

View source ↗

Summary

Astellas announced the completion of a combined Phase 1/2 safety, tolerability and efficacy study of ASK8007 for rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ASK8007

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Rheumatoid Arthritis | Phase 1, Phase 2 | Status: COMPLETED